Increased serum level of early prostate cancer antigen is associated with subsequent cancer risk in men with high-grade prostatic intraepithelial neoplasia

Endocrine-Related Cancer

Volumn 17, Issue 2, 2010, Pages 505-512

  Zhao, Zhigang ^a   Zeng, Guohua ^a  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EARLY PROSTATE CANCER ANTIGEN; PROSTATE SPECIFIC ANTIGEN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER RISK; DIGITAL RECTAL EXAMINATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PROSTATIC INTRAEPITHELIAL NEOPLASIA;

AGED; ANTIGENS, NEOPLASM; CASE-CONTROL STUDIES; DISEASE PROGRESSION; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PRECANCEROUS CONDITIONS; PROGNOSIS; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 77953576174     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1677/ERC-10-0017     Document Type: Article

References (31)

1. Abdel-Khalek M, El-BazM& Ibrahiem el-H 2004 Predictors of prostate cancer on extended biopsy in patients with high grade prostatic intraepithelial neoplasia: a multivariate analysis model. British Journal of Urology International 94 528-533.
2. Akhavan A, Keith JD, Bastacky SI, Cai C, Wang Y & Nelson JB 2007 The proportion of cores with highgrade prostatic intraepithelial neoplasia on extendedpattern needle biopsy is significantly associated with prostate cancer on site-directed repeat biopsy. British Journal of Urology International 99 765-769.
3. Ayala AG & Ro JY 2007 Prostatic intraepithelial neoplasia: recent advances. Archives of Pathology & Laboratory Medicine 131 1257-1266. (Pubitemid 47257638)
4. Cheng L, Paterson RF, Beck SD & Parks J 2004 Prostatic intraepithelial neoplasia: an update. Clinical Prostate Cancer 3 26-30.
5. Chin AI, Dave DS & Rajfer J 2007 Is repeat biopsy for isolated high-grade prostatic intraepithelial neoplasia necessary? Reviews in Urology 9 124-131.
6. Crawford ED & Abrahamsson PA 2008 PSA-based screening for prostate cancer: how does it compare with other cancer screening tests? European Urology 54 262-273.
7. Dhir R, Vietmeier B, Arlotti J, Acquafondata M, Landsittel D, Masterson R & Getzenberg RH 2004 Early identification of individuals with prostate cancer in negative biopsies. Journal of Urology 171 1419-1423.
8. Dovey Z, Corbishley CM & Kirby RS 2005 Prostatic intraepithelial neoplasia: a risk factor for prostate cancer. Canadian Journal of Urology 12 (Supplement 1) 49-52.
9. Freeman AA 2006 Precursor lesions of prostatic adenocarcinoma. In Prostate Cancer Principles and Practice, edn 1, pp 122. Eds RS Kirby, AW Partin, M Feneley & JK Parsons. London, UK: Taylor & Francis.
10. Godoy G & Taneja SS 2008 Contemporary clinical management of isolated high-grade prostatic intraepithelial neoplasia. Prostate Cancer and Prostatic Diseases 11 20-31.
11. Gokden N, Roehl KA, Catalona WJ & Humphrey PA 2005 High-grade prostatic intraepithelial neoplasia in needle biopsy as risk factor for detection of adenocarcinoma: current level of risk in screening population. Urology 65 538-542.
12. Haese A, de la Taille A, van Poppel H, Marberger M, Stenzl A, Mulders PF, Huland H, Abbou CC, Remzi M, Tinzl M et al. 2008 Clinical utility of PCA3 urine assay in European men scheduled for repeat biopsy. European Urology 54 1081-1088.
13. Hansel DE, DeMarzo AM, Platz EA, Jadallah S, Hicks J, Epstein JI, Partin AW & Netto GJ 2007 Early prostate cancer antigen expression in predicting presence of prostate cancer in men with histologically negative biopsies. Journal of Urology 177 1736-1740.
14. Henshall SM, Quinn DI, Lee CS, Head DR, Golovsky D, Brenner PC, Delprado W, Stricker PD, Grygiel JJ & Sutherland RL 2001 Overexpression of the cell cycle inhibitor p16INK4A in highgrade prostatic intraepithelial neoplasia predicts early relapse in prostate cancer patients. Clinical Cancer Research 7 544-550. (Pubitemid 32707976)
15. Herawi M, Kahane H, Cavallo C & Epstein JI 2006 Risk of prostate cancer on first re-biopsy within 1 year following a diagnosis of high grade prostatic intraepithelial neoplasia is related to the number of cores sampled. Journal of Urology 175 121-124.
16. Jansen FH, Roobol M, Jenster G, Schröder FH & Bangma CH 2009 Screening for prostate cancer in 2008 II: the importance of molecular subforms of prostate-specific antigen and tissue kallikreins. European Urology 55 563-574.
17. Joniau S, Goeman L, Pennings J & Van Poppel H 2005 Prostatic intraepithelial neoplasia (PIN): importance and clinical management. European Urology 48 379-385.
18. Leman ES, Cannon GW, Trock BJ, Sokoll LJ, Chan DW, Mangold L, Partin AW & Getzenberg RH 2007 EPCA-2: a highly specific serum marker for prostate cancer. Urology 69 714-720.
19. Leman ES, Magheli A, Cannon GW, Mangold L, Partin AW & Getzenberg RH 2009 Analysis of a serum test for prostate cancer that detects a second epitope of EPCA-2. Prostate 69 1188-1194.
20. Loeb S, Roehl KA, Yu X, HanM& Catalona WJ 2007 Use of prostate specific antigen velocity to follow up patients with isolated high-grade prostatic intraepithelial neoplasia on prostate biopsy. Urology 69 108-112.
21. Montironi R, Mazzucchelli R, Lopez-Beltran A, Cheng L & Scarpelli M 2007 Mechanisms of disease: high-grade prostatic intraepithelial neoplasia and other proposed preneoplastic lesions in the prostate. Nature Clinical Practice. Urology 4 321-332.
22. Moore CK, Karikehalli S, Nazeer T, Fisher HA, Kaufman RP Jr & Mian BM 2005 Prognostic significance of high grade prostatic intraepithelial neoplasia and atypical small acinar proliferation in the contemporary era. Journal of Urology 173 70-72.
23. Paul B, Dhir R, Landsittel D, Hitchens MR & Getzenberg RH 2005 Detection of prostate cancer with a blood-based assay for early prostate cancer antigen. Cancer Research 65 4097-4100.
24. Roscigno M, Scattoni V, Freschi M, Raber M, Colombo R, Bertini R, Montorsi F & Rigatti P 2004 Monofocal and plurifocal high-grade porstatic intraepithelial neoplasia on extended prostate biopsies: factors predicting cancer detection on extended repeat biopsy. Urology 63 1105-1110.
25. Schröder FH, Carter HB, Wolters T, van den Bergh RC, Gosselaar C, Bangma CH & Roobol MJ 2008 Early detection of prostate cancer in 2007. Part 1: PSA and PSA kinetics. European Urology 53 468-477.
26. Singh H, Canto EI, Shariat SF, Kadmon D, Miles BJ, Wheeler TM & Slawin KM 2004 Predictors of prostate cancer after initial negative systematic 12 core biopsy. Journal of Urology 171 1850-1854.
27. Sinha AA, Quast BJ, Reddy PK, Lall V, Wilson MJ, Qian J & Bostwick DG 2004 Microvessel density as a molecular marker for identifying high-grade prostatic intraepithelial neoplasia precursors to prostate cancer. Experimental and Molecular Pathology 77 153-159.
28. Steuber T, O'Brien MF & Lilja H 2008 Serum markers for prostate cancer: a rational approach to the literature. European Urology 54 31-40.
29. Uetsuki H, Tsunemori H, Taoka R, Haba R, Ishikawa M & Kakehi Y 2005 Expression of a novel biomarker, EPCA, in adenocarcinomas and precancerous lesions in the prostate. Journal of Urology 174 514-518.
30. Welch HG, Schwartz LM & Woloshin S 2005 Prostate-specific antigen levels in the United States: implications of various definitions for abnormal. Journal of the National Cancer Institute 97 1132-1137.
31. Zhao ZG & Shen WL 2007 Prostate stem cell antigen (PSCA) mRNA expression in prostatic intraepithelial neoplasia: implications for the development of prostate cancer. Prostate 67 1143-1151.